Kessara Pathanapitoon
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Kessara Pathanapitoon has a total of 553 co-authors. Here are the top co-authors by number of shared publications:
- Paradee Kunavisarut
Retina Division, Department of Ophthalmology, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand
35 shared publications Aniki Rothova
Department of Ophthalmology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands
27 shared publications- Janejit Choovuthayakorn
Department of Ophthalmology, Faculty of Medicine, Chiang Mai University, Chiang Mai 50200, Thailand
8 shared publications Direk Patikulsila
Chiang Mai University
6 shared publicationsNatedao Kongyai
Division of Clinical Microbiology, Department of Medical Technology, Faculty of Associated Medical Sciences
6 shared publicationsWasna Sirirungsi
B Department of Medical Technology, Faculty of Associated Medical Sciences , Chiang Mai University , Thailand
6 shared publications
Latest Publications
- Open Access
- 1 July 2026
- Published by Chiang Mai University in Biomedical Sciences and Clinical Medicine
- Vol. 65 (3) , 322-333
Repeatability and Reproducibility of an Automated Image-Processing Software for Quantitative Conjunctival Hyperemia Analysis: A Pilot Study
OBJECTIVE Conjunctival hyperemia reflects the severity of various ocular conditions and is a common side effect of glaucoma medications, posing a significant concern for affected patients. Most existing clinical grading systems are subjective and rely heavily on individual physician interpretation, making interobserver comparison difficult. We developed an automated grading software to objectively and quantitatively assess conjunctival hyperemia. This study aimed to evaluate the repeatability and reproducibility of a newly developed automated software for quantitative assessment of conjunctival hyperemia in glaucoma patients in a pilot validation study. METHODS In this pilot study, glaucoma patients using at least one topical anti-glaucoma medication and exhibiting conjunctival hyperemia were enrolled. Each patient’s conjunctival hyperemia was assessed using the automated software, which segmented images into four regions: blood vessel area, strong red area, weak red area, and non-red area. An automatic region of interest (ROI) registration function was incorporated to enhance measurement consistency. Repeatability was assessed using two measurements from the same image, and reproducibility was tested using separate images of the same eye. RESULTS Eighty images from twenty glaucoma patients were analyzed (collected between December 1, 2016, and December 31, 2018). Following administration of 10% phenylephrine ophthalmic solution, the percentage of conjunctival hyperemia decreased significantly in all regions (p < 0.001). Spearman correlation coefficients for repeated measurements on the same image were 0.884 (blood vessel), 0.982 (strong red), and 0.932 (weak red). Corresponding values for repeated images of the same eye were 0.988, 0.992, and 0.995, respectively. The intraclass correlation coefficient (ICC) for clinical grading by ten ophthalmologists was 0.969 (95% CI: 0.952–0.981). CONCLUSION This pilot study demonstrates that the proposed automated software provides an objective and quantitative assessment of conjunctival hyperemia with excellent repeatability and reproducibility. The system shows high correlation with clinical grading and may serve as a reliable tool for monitoring conjunctival hyperemia changes in clinical practice.
- 1 July 2026
- Published by Chiang Mai University in Biomedical Sciences and Clinical Medicine
- Vol. 65 (3) , 322-333
Open AccessRepeatability and Reproducibility of an Automated Image-Processing Software for Quantitative Conjunctival Hyperemia Analysis: A Pilot Study
OBJECTIVE Conjunctival hyperemia reflects the severity of various ocular conditions and is a common side effect of glaucoma medications, posing a significant concern for affected patients. Most existing clinical grading systems are subjective and rely heavily on individual physician interpretation, making interobserver comparison difficult. We developed an automated grading software to objectively and quantitatively assess conjunctival hyperemia. This study aimed to evaluate the repeatability and reproducibility of a newly developed automated software for quantitative assessment of conjunctival hyperemia in glaucoma patients in a pilot validation study. METHODS In this pilot study, glaucoma patients using at least one topical anti-glaucoma medication and exhibiting conjunctival hyperemia were enrolled. Each patient’s conjunctival hyperemia was assessed using the automated software, which segmented images into four regions: blood vessel area, strong red area, weak red area, and non-red area. An automatic region of interest (ROI) registration function was incorporated to enhance measurement consistency. Repeatability was assessed using two measurements from the same image, and reproducibility was tested using separate images of the same eye. RESULTS Eighty images from twenty glaucoma patients were analyzed (collected between December 1, 2016, and December 31, 2018). Following administration of 10% phenylephrine ophthalmic solution, the percentage of conjunctival hyperemia decreased significantly in all regions (p < 0.001). Spearman correlation coefficients for repeated measurements on the same image were 0.884 (blood vessel), 0.982 (strong red), and 0.932 (weak red). Corresponding values for repeated images of the same eye were 0.988, 0.992, and 0.995, respectively. The intraclass correlation coefficient (ICC) for clinical grading by ten ophthalmologists was 0.969 (95% CI: 0.952–0.981). CONCLUSION This pilot study demonstrates that the proposed automated software provides an objective and quantitative assessment of conjunctival hyperemia with excellent repeatability and reproducibility. The system shows high correlation with clinical grading and may serve as a reliable tool for monitoring conjunctival hyperemia changes in clinical practice.
- Open Access
- 21 April 2026
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 26 (1)
Interferon-gamma autoantibodies in patients with infectious uveitis: a pilot case–control study
To investigate the association between infectious uveitis in immunocompetent individuals and adult-onset immunodeficiency (AOID). A pilot prospective obser
- 21 April 2026
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 26 (1)
Open AccessInterferon-gamma autoantibodies in patients with infectious uveitis: a pilot case–control study
To investigate the association between infectious uveitis in immunocompetent individuals and adult-onset immunodeficiency (AOID). A pilot prospective obser
- Open Access
- 8 September 2025
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 20 (9) , e0331586
Comparative biocompatibility of hydrophilic vs. hydrophobic intraocular lenses following phacoemulsification in patients with uveitis
Purpose: To evaluate and compare the biocompatibility of hydrophilic and hydrophobic intraocular lenses (IOLs) in patients with uveitis undergoing phacoemulsification, with particular focus on posterior capsule opacification (PCO), postoperative inflammation, and visual outcomes. Methods: Patients with uveitis who underwent phacoemulsification with IOL implantation between 2015 and 2023 were retrospectively reviewed. Propensity score matching (1:1) was performed to account for clinical and demographic variables, yielding 132 eyes (66 per group) for analysis. Primary outcomes included the incidence of PCO and the need for neodymium-doped yttrium aluminum garnet (Nd:YAG) laser capsulotomy. Secondary outcomes were the rate of uveitis reactivation and visual improvement. Cox regression models were used to estimate adjusted hazard ratios (HRs) with 95% confidence intervals (CIs). Results: Hydrophobic IOLs were significantly associated with a reduced risk of PCO (adjusted HR = 0.35; 95% CI, 0.18–0.68; p < 0.05) and Nd:YAG capsulotomy (adjusted HR = 0.23; 95% CI, 0.09–0.56; p < 0.05) compared to hydrophilic IOLs. No significant difference was found in the rate of uveitis reactivation between groups (adjusted HR = 0.83; 95% CI, 0.37–1.88; p = 0.643). Conclusion: Hydrophobic intraocular lenses show better capsular biocompatibility in uveitic eyes by significantly reducing the incidence of PCO and need for Nd:YAG capsulotomy, without increasing postoperative inflammation. These findings support the preferential use of hydrophobic acrylic IOLs in cataract surgery for patients with uveitis.
- 8 September 2025
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 20 (9) , e0331586
Open AccessComparative biocompatibility of hydrophilic vs. hydrophobic intraocular lenses following phacoemulsification in patients with uveitis
Purpose: To evaluate and compare the biocompatibility of hydrophilic and hydrophobic intraocular lenses (IOLs) in patients with uveitis undergoing phacoemulsification, with particular focus on posterior capsule opacification (PCO), postoperative inflammation, and visual outcomes. Methods: Patients with uveitis who underwent phacoemulsification with IOL implantation between 2015 and 2023 were retrospectively reviewed. Propensity score matching (1:1) was performed to account for clinical and demographic variables, yielding 132 eyes (66 per group) for analysis. Primary outcomes included the incidence of PCO and the need for neodymium-doped yttrium aluminum garnet (Nd:YAG) laser capsulotomy. Secondary outcomes were the rate of uveitis reactivation and visual improvement. Cox regression models were used to estimate adjusted hazard ratios (HRs) with 95% confidence intervals (CIs). Results: Hydrophobic IOLs were significantly associated with a reduced risk of PCO (adjusted HR = 0.35; 95% CI, 0.18–0.68; p < 0.05) and Nd:YAG capsulotomy (adjusted HR = 0.23; 95% CI, 0.09–0.56; p < 0.05) compared to hydrophilic IOLs. No significant difference was found in the rate of uveitis reactivation between groups (adjusted HR = 0.83; 95% CI, 0.37–1.88; p = 0.643). Conclusion: Hydrophobic intraocular lenses show better capsular biocompatibility in uveitic eyes by significantly reducing the incidence of PCO and need for Nd:YAG capsulotomy, without increasing postoperative inflammation. These findings support the preferential use of hydrophobic acrylic IOLs in cataract surgery for patients with uveitis.
- Open Access
- 1 February 2025
- Published by Taylor & Francis in Clinical Ophthalmology
- Vol. ume 19, 543-551
Prevalence and Risk Factors for Ocular Complications in New-Onset Uveitis: A Study From a Tertiary Referral Center in Northern Thailand
Purpose: To determine the prevalence and identify risk factors of ocular complications in patients with uveitis. Methods: This retrospective study reviewed of 340 consecutive patients with a first episode of active uveitis from January 2015 to December 2019. Demographic and clinical data, including ocular complications were analyzed. Results: The mean age of the cohort was 47 years. Among them, 75 patients were HIV-positive (74% male), and 265 were HIV-negative (53% male). An Infectious etiology was identified in 52% of cases. Ocular complications, developed in 151 patients (44%), with their type strongly correlate to the anatomical location of uveitis. Multivariate analysis revealed chronic inflammation (risk ratio [RR]=18.9; 95% confidence interval [CI] 6.1– 58.8), recurrent inflammation (RR=20.4; 95%; CI 6.5– 64.3), and poor visual acuity (VA) at presentation (RR=3.6; 95% CI 1.4– 9.2) as significant risk factors for complications. Conclusion: Nearly half of the patients with uveitis developed ocular complications, highlighting the importance of identifying risk factors. Understanding the relationship between the location of inflammation and specific complication patterns is essential for early detection and targeted prevention strategies.
- 1 February 2025
- Published by Taylor & Francis in Clinical Ophthalmology
- Vol. ume 19, 543-551
Open AccessPrevalence and Risk Factors for Ocular Complications in New-Onset Uveitis: A Study From a Tertiary Referral Center in Northern Thailand
Purpose: To determine the prevalence and identify risk factors of ocular complications in patients with uveitis. Methods: This retrospective study reviewed of 340 consecutive patients with a first episode of active uveitis from January 2015 to December 2019. Demographic and clinical data, including ocular complications were analyzed. Results: The mean age of the cohort was 47 years. Among them, 75 patients were HIV-positive (74% male), and 265 were HIV-negative (53% male). An Infectious etiology was identified in 52% of cases. Ocular complications, developed in 151 patients (44%), with their type strongly correlate to the anatomical location of uveitis. Multivariate analysis revealed chronic inflammation (risk ratio [RR]=18.9; 95% confidence interval [CI] 6.1– 58.8), recurrent inflammation (RR=20.4; 95%; CI 6.5– 64.3), and poor visual acuity (VA) at presentation (RR=3.6; 95% CI 1.4– 9.2) as significant risk factors for complications. Conclusion: Nearly half of the patients with uveitis developed ocular complications, highlighting the importance of identifying risk factors. Understanding the relationship between the location of inflammation and specific complication patterns is essential for early detection and targeted prevention strategies.
- Open Access
- 1 April 2024
- Published by Chiang Mai University in Biomedical Sciences and Clinical Medicine
- Vol. 63 (2) , 55-62
Clinical Characteristics and Outcomes of Primary Vitreoretinal Lymphoma in Northern Thailand
OBJECTIVE This study aims to describe clinical characteristics and outcomes after treatment of primary vitreoretinal lymphoma (PVRL). METHODS Fifteen patients with a proven diagnosis of PVRL by histology, cytology and/or flow cytometry were analyzed. RESULTS The median age of the 15 patients was 59 years (range 41-71). Median follow-up time was 37 months (IQR 22.5-80) (range 4-106). Ophthalmic presentations of 25 eyes included vitritis (72%), chorioretinal infiltrations (60%), and retinal vasculitis (20%). Bilateral involvement was observed in 10 patients at presentation and in 4 patients during follow up. Ten patients (67%) developed brain involvement after ocular presentation with a median time of 22.5 months (range 2-84). Treatment modalities were included: 1) isolated intravitreal (IVT) methotrexate (6/15 patients; 40%) with a median number of injections of 4 (IQR 1,6) (range 1-16) 2) combined with IVT metho-trexate and/or rituximab and systemic chemotherapy and/or radiation (8/15; 53%) with a median of 6 injections (IQR 1,11) (range 1-16) and 3) systemic chemotherapy alone (1/15; 7%). Whole brain radiotherapy (WBRT) was performed in 10 of 15 patients (67%). Among the 6 patients who received isolated IVT methotrexate, 3 patients had complete remission (3/6; 50%), one died at 96 months after treatment, and one was lost to follow up after a single injection. Nine of 15 patients who received systemic chemotherapy with or without IVT chemotherapy and/or WBRT had complete remission (8/9; 89%). CONCLUSIONS Vitritis and chorioretinal infiltrations were the main ocular presentations of PVRL. Two-thirds of the patients developed brain involvement which resolved after treatment. Systemic chemotherapy tends to provide a higher rate of complete remission compared to local therapy alone.
- 1 April 2024
- Published by Chiang Mai University in Biomedical Sciences and Clinical Medicine
- Vol. 63 (2) , 55-62
Open AccessClinical Characteristics and Outcomes of Primary Vitreoretinal Lymphoma in Northern Thailand
OBJECTIVE This study aims to describe clinical characteristics and outcomes after treatment of primary vitreoretinal lymphoma (PVRL). METHODS Fifteen patients with a proven diagnosis of PVRL by histology, cytology and/or flow cytometry were analyzed. RESULTS The median age of the 15 patients was 59 years (range 41-71). Median follow-up time was 37 months (IQR 22.5-80) (range 4-106). Ophthalmic presentations of 25 eyes included vitritis (72%), chorioretinal infiltrations (60%), and retinal vasculitis (20%). Bilateral involvement was observed in 10 patients at presentation and in 4 patients during follow up. Ten patients (67%) developed brain involvement after ocular presentation with a median time of 22.5 months (range 2-84). Treatment modalities were included: 1) isolated intravitreal (IVT) methotrexate (6/15 patients; 40%) with a median number of injections of 4 (IQR 1,6) (range 1-16) 2) combined with IVT metho-trexate and/or rituximab and systemic chemotherapy and/or radiation (8/15; 53%) with a median of 6 injections (IQR 1,11) (range 1-16) and 3) systemic chemotherapy alone (1/15; 7%). Whole brain radiotherapy (WBRT) was performed in 10 of 15 patients (67%). Among the 6 patients who received isolated IVT methotrexate, 3 patients had complete remission (3/6; 50%), one died at 96 months after treatment, and one was lost to follow up after a single injection. Nine of 15 patients who received systemic chemotherapy with or without IVT chemotherapy and/or WBRT had complete remission (8/9; 89%). CONCLUSIONS Vitritis and chorioretinal infiltrations were the main ocular presentations of PVRL. Two-thirds of the patients developed brain involvement which resolved after treatment. Systemic chemotherapy tends to provide a higher rate of complete remission compared to local therapy alone.
- 12 April 2023
- Published by Taylor & Francis in Ocular Immunology and Inflammation
- Vol. 32 (5) , 652-657
Clinical and Microbiological Manifestations of Endogenous Endophthalmitis in Tertiary Care Hospital, Northern Thailand
To determine the characteristics, primary sources, pathogens, risk factors, and visual outcomes in patients with endogenous endophthalmitis (EE).We performed a retrospective cohort study of 61 cons...
- 12 April 2023
- Published by Taylor & Francis in Ocular Immunology and Inflammation
- Vol. 32 (5) , 652-657
Clinical and Microbiological Manifestations of Endogenous Endophthalmitis in Tertiary Care Hospital, Northern Thailand
To determine the characteristics, primary sources, pathogens, risk factors, and visual outcomes in patients with endogenous endophthalmitis (EE).We performed a retrospective cohort study of 61 cons...
- Open Access
- 17 March 2023
- Published by JMIR Publications Inc. in JMIR Preprints
Repeatability and Reproducibility of Automated Quantitative Conjunctival Hyperemia Analysis Software (Preprint)
BACKGROUND The degree of conjunctival hyperemia reflects the severity of various ocular disease. Most of clinical grading systems rely on individual physicians and it is difficult to compare between clinical examinations. We developed automated grading software to objectively assess conjunctival hyperemia. OBJECTIVE To assess the repeatability and reproducibility of newly developed automated quantitative conjunctival hyperemia analysis software. METHODS Eighty images of twenty glaucoma patients who were using at least one anti-glaucoma medication and complained of conjunctival hyperemia were collected. All patients’ severity of conjunctival hyperemia was evaluated by newly developed automated conjunctival hyperemia grading software into 4 levels: blood vessel, strong red area, weak red area and non-red area. Automatic registration was applied for improving the software repeatability and reproducibility. RESULTS Spearman correlation coefficient values(rs) values of 0.884, 0.982 and 0.932 for blood vessel area, strong red area and weak red area of two measurements of the same image, respectively. Spearman correlation coefficient (rs) values of 0.988, 0.992 and 0.995 for blood vessel area, strong red area and weak red area of two images of the same eye, respectively. The clinical grading had the best correlation with the summation of blood vessel and strong red area, following with strong red area. CONCLUSIONS The proposed conjunctival hyperemia analysis software provides an automatically quantitative objective assessment of conjunctival hyperemia with excellent repeatability and reproducibility including excellent correlation with clinical grading by ophthalmologists. This algorithm including the automatic region of interest (ROI) registration between two images system give precise results in comparing the conjunctival hyperemic change in clinical practice.
- 17 March 2023
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessRepeatability and Reproducibility of Automated Quantitative Conjunctival Hyperemia Analysis Software (Preprint)
BACKGROUND The degree of conjunctival hyperemia reflects the severity of various ocular disease. Most of clinical grading systems rely on individual physicians and it is difficult to compare between clinical examinations. We developed automated grading software to objectively assess conjunctival hyperemia. OBJECTIVE To assess the repeatability and reproducibility of newly developed automated quantitative conjunctival hyperemia analysis software. METHODS Eighty images of twenty glaucoma patients who were using at least one anti-glaucoma medication and complained of conjunctival hyperemia were collected. All patients’ severity of conjunctival hyperemia was evaluated by newly developed automated conjunctival hyperemia grading software into 4 levels: blood vessel, strong red area, weak red area and non-red area. Automatic registration was applied for improving the software repeatability and reproducibility. RESULTS Spearman correlation coefficient values(rs) values of 0.884, 0.982 and 0.932 for blood vessel area, strong red area and weak red area of two measurements of the same image, respectively. Spearman correlation coefficient (rs) values of 0.988, 0.992 and 0.995 for blood vessel area, strong red area and weak red area of two images of the same eye, respectively. The clinical grading had the best correlation with the summation of blood vessel and strong red area, following with strong red area. CONCLUSIONS The proposed conjunctival hyperemia analysis software provides an automatically quantitative objective assessment of conjunctival hyperemia with excellent repeatability and reproducibility including excellent correlation with clinical grading by ophthalmologists. This algorithm including the automatic region of interest (ROI) registration between two images system give precise results in comparing the conjunctival hyperemic change in clinical practice.
- 11 January 2023
- Published by Taylor & Francis in Ocular Immunology and Inflammation
- Vol. 32 (2) , 190-193
The Presence of Pigmentation on Central Anterior Lens Capsule in the Human Leukocyte Antigen B27-Associated Anterior Uveitis and Its Value in Clinical Diagnosis
To report on the value of presence of pigmentation on central anterior lens capsule (PioLe) in HLA B27- associated anterior uveitis (HLA B27-AU).268 patients (320 eyes) with AU were reviewed. Two d...
- 11 January 2023
- Published by Taylor & Francis in Ocular Immunology and Inflammation
- Vol. 32 (2) , 190-193
The Presence of Pigmentation on Central Anterior Lens Capsule in the Human Leukocyte Antigen B27-Associated Anterior Uveitis and Its Value in Clinical Diagnosis
To report on the value of presence of pigmentation on central anterior lens capsule (PioLe) in HLA B27- associated anterior uveitis (HLA B27-AU).268 patients (320 eyes) with AU were reviewed. Two d...
- Open Access
- 1 April 2022
- Published by Galenos Yayinevi in Turkish Journal of Ophthalmology
- Vol. 52 (2) , 109-118
Idiopathic Epiretinal Membranes: Visual Outcomes and Prognostic Factors
İdiyopatik Epiretinal Membranlar: Görme Sonuçları ve Prognostik Faktörler
- 1 April 2022
- Published by Galenos Yayinevi in Turkish Journal of Ophthalmology
- Vol. 52 (2) , 109-118
Open AccessIdiopathic Epiretinal Membranes: Visual Outcomes and Prognostic Factors
İdiyopatik Epiretinal Membranlar: Görme Sonuçları ve Prognostik Faktörler
- 2 October 2019
- Published by Taylor & Francis in Ocular Immunology and Inflammation
- Vol. 28 (7) , 1066-1068
Case Report: Bilateral Granulomatous Anterior Uveitis in HIV-patient with Disseminated Talaromycosis (penicilliosis) Marneffei Infection
We report on a 22-years-old Thai male patient with congenital HIV infection. Due to his non-adherence to antiretroviral treatment he developed disseminated Talaromyces marneffei infection and was treated with intravenous amphotericin B. Despite this treatment, he presented with bilateral granulomatous anterior uveitis. Uveitis improved only after intracameral injection of amphotericin B.
- 2 October 2019
- Published by Taylor & Francis in Ocular Immunology and Inflammation
- Vol. 28 (7) , 1066-1068
Case Report: Bilateral Granulomatous Anterior Uveitis in HIV-patient with Disseminated Talaromycosis (penicilliosis) Marneffei Infection
We report on a 22-years-old Thai male patient with congenital HIV infection. Due to his non-adherence to antiretroviral treatment he developed disseminated Talaromyces marneffei infection and was treated with intravenous amphotericin B. Despite this treatment, he presented with bilateral granulomatous anterior uveitis. Uveitis improved only after intracameral injection of amphotericin B.